Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $505.75 | Total: $2,528.75 |
| 1 | 10 | $428.40 | Total: $4,284.00 |
| 1 | 25 | $362.95 | Total: $9,073.75 |
| 1 | 50 | $309.40 | Total: $15,470.00 |
| 1 | 100 | $267.75 | Total: $26,775.01 |
Overview
CHF5407?SVT-47060? is a potent and selective muscarinic M3 receptor antagonist with prolonged action at muscarinic receptors.CHF5407 has an effect on bronchospasm and may be used in the study of respiratory disorders.CHF5407 is a potent and selective muscarinic M3 receptor antagonist with prolonged action at muscarinic receptors.
Chemical Properties
| Molecular Formula | C27H25BrF4N2O3S |
| Molecular Weight | 613.46 |
| CAS Numbers | 1004312-94-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C(=O)C1=CC=CS1)[N+]23C[C@H](OC(N(CC4=CC(F)=C(F)C(F)=C4)C5=CC(F)=CC=C5)=O)C(CC2)CC3.[Br-] |
Storage and Handling
0C Short Term, -20C Long Term
References
Villetti G, et al. Bronchodilator activity of[3R]-3-[[[[3-fluorophenyl][[3,4,5-trifluorophenyl]methyl]amino] carbonyl]oxy]-1-[2-oxo-2-[2-thienyl]ethyl]-1-azoniabicyclo[2.2.2]octane bromide [CHF5407],a potent,long-acting, and selective muscarinic M3 receptor antagonist. J Pharmacol Exp Ther. 2010 Dec;335[3] 622-35.